Determination of Oral Dosage and Pharmacokinetic Analysis of Flecainide in Horses

Journal of Veterinary Medical Science

Volumn 63, Issue 5, 2001, Pages 511-514

  Ohmura, Hajime ^a   Hiraga, Atsushi ^a   Aida, Hiroko ^a   Takahashi, Toshiyuki ^b   Nukada, Toshio ^b  

^a Equine Science Division   (Japan)

^b EQUINE RESEARCH INSTITUTE   (Japan)

Author keywords

Equine; Flecainide; Oral administration; Pharmacokinetics

Indexed keywords

EQUIDAE;

ANTIARRHYTHMIC AGENT; FLECAINIDE;

ANIMAL; ANIMAL DISEASE; AREA UNDER THE CURVE; ARTICLE; BLOOD; DRUG EFFECT; ELECTROCARDIOGRAPHY; FEMALE; HALF LIFE TIME; HEART RATE; HORSE; MALE; METABOLISM; ORAL DRUG ADMINISTRATION; RANDOMIZATION;

ADMINISTRATION, ORAL; ANIMALS; ANTI-ARRHYTHMIA AGENTS; AREA UNDER CURVE; ELECTROCARDIOGRAPHY; FEMALE; FLECAINIDE; HALF-LIFE; HEART RATE; HORSES; MALE; RANDOM ALLOCATION;

EID: 0035346116     PISSN: 09167250     EISSN: None     Source Type: Journal    
DOI: 10.1292/jvms.63.511     Document Type: Article

References (11)

1. Atarashi, H., Saito, H., Onodera, T., Kobayashi, Y., Koh, M., Sasaki, H., Yasutake, M., Hayakawa, H., Shimomura, M. and Morishita, N. 1996. Phase I study of flecainide acetate (E0735) injection. Jpn. J. Clin. Pharmacil. Ther. 27: 713-723 (in Japanese).
2. Conard, G.J. and Ober, R.E. 1984. Metabolism of flecainide. Am. J. Cardiol. 53: 41B-51B.
3. Duff, H.J., Roden, D.M., Maffucci, R.J., Vesper, B.S., Conard, G.J., Higgins, S.B., Oates, J.A., Smith, R.F. and Woosley, R.L. 1981. Suppression of resistant ventricular arrhythmias by twice daily dosing with flecainide. Am. J. Cardiol. 48: 1133-1140.
4. Hellestrand, K.J., Bexton, R.S., Nathan, A.W., Spurrell, R.A. and Camm, A.J. 1982. Acute electrophysiological effects of flecainide acetate on cardiac conduction and refractoriness in man. Br. Heart J. 48: 140-148.
5. Kingma, J.H. and Suttorp, M.J. 1992. Acute pharmacologic conversion of atrial fibrillation and flutter: the role of flecainide, propafenone, and verapamil. Am. J. Cardiol. 70: 56A-61A.
6. Kvam, D.C., Banitt, E.H. and Schmid, J.R. 1984. Antiarrhythmic and electrophysiologic actions of flecainide in animal models. Am. J. Cardiol. 53: 22B-25B.
7. Madrid, A.H., Moro, C., Marin-Huerta, E., Mestre, J.L., Novo, L. and Costa, A. 1993. Comparison of flecainide and procainamide in cardioversion of atrial fibrillation. Eur. Heart J. 14: 1127-1131.
8. Ohmura, H., Nukada, T., Mizuno, Y., Yamaya, Y., Nakayama, T. and Amada, A. 2000. Safe and efficacious dosage of flecainide acetate for treating equine atrial fibrillation. J. Vet. Med. Sci. 62: 711-715.
9. Piovan, D., Padrini, R., Furlanut, M., Moretto, R. and Ferrari, M. 1986. Plasma and tissue levels of flecainide in rats. Pharmacol. Res. Commun. 18: 739-745.
10. Suttorp, M.J., Kingma, J.H., Lie, A., Huen, L. and Mast, E.G. 1989. Intravenous flecainide versus verapamil for acute conversion of paroxysmal atrial fibrillation or flutter to sinus rhythm. Am. J. Cardiol. 63: 693-696.
11. Suttorp, M.J., Kingma, J.H., Jessurun, E.R., Lie, A., Huen, L., van Hemel, N.M. and Lie, K.I. 1990. The value of class IC antiarrhythmic drugs for acute conversion of paroxysmal atrial fibrillation or flutter to sinus rhythm. J. Am. Coll. Cardiol. 16: 1722-1727.